Towards precision medicine: Therapeutic drug monitoring–guided dosing of vancomycin and β-lactam antibiotics to maximize effectiveness and minimize toxicity

Author:

Cusumano Jaclyn A12,Klinker Kenneth P3,Huttner Angela4,Luther Megan K12,Roberts Jason A56,LaPlante Kerry L12

Affiliation:

1. Infectious Diseases Research Program, Veterans Affairs Medical Center, Providence, RI

2. Department of Pharmacy Practice, College of Pharmacy, University of Rhode Island, Kingston, RI

3. Merck & Co., Inc., Kenilworth, NJ

4. Division of Infectious Diseases, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland

5. University of Queensland Centre for Clinical Research (UQCCR), Faculty of Medicine & Centre for Translational Anti-infective Pharmacodynamics, School of Pharmacy, University of Queensland, Brisbane, Australia

6. Royal Brisbane and Women’s Hospital, Brisbane, Australia

Abstract

Abstract Purpose The goal of this review is to explore the role of antimicrobial therapeutic drug monitoring (TDM), especially in critically ill, obese, and older adults, with a specific focus on β-lactams and vancomycin. Summary The continued rise of antimicrobial resistance prompts the need to optimize antimicrobial dosing. The aim of TDM is to individualize antimicrobial dosing to achieve antibiotic exposures associated with improved patient outcomes. Initially, TDM was developed to minimize adverse effects during use of narrow therapeutic index agents. Today, patient and organism complexity are expanding the need for precision dosing through TDM services. Alterations of pharmacokinetics and pharmacodynamics (PK/PD) in the critically ill, obese, and older adult populations, in conjunction with declining organism susceptibility, complicate attainment of therapeutic targets. Over the last decade, antimicrobial TDM has expanded with the emergence of literature supporting β-lactam TDM and a shift from monitoring vancomycin trough concentrations to monitoring of the ratio of area under the concentration (AUC) curve to minimum inhibitory concentration (MIC). PK/PD experts should be at the forefront of implementing precision dosing practices. Conclusion Precision dosing through TDM is expanding and is especially important in populations with altered PK/PD, including critically ill, obese, and older adults. Due to wide PK/PD variability in these populations, TDM is vital to maximize antimicrobial effectiveness and decrease adverse event rates. However, there is still a need for studies connecting TDM to patient outcomes. Providing patient-specific care through β-lactam TDM and transitioning to vancomycin AUC/MIC monitoring may be challenging, but with experts at the forefront of this initiative, PK-based optimization of antimicrobial therapy can be achieved.

Publisher

Oxford University Press (OUP)

Subject

Health Policy,Pharmacology

Reference73 articles.

1. Therapeutic drug monitoring in the past 40 years of the Journal of Antimicrobial Chemotherapy;Reeves;J Antimicrob Chemother.,2016

2. Protein binding of beta-lactams: the effects on activity and pharmacology, particularly tissue penetration. II. Studies in man;Wise;J Antimicrob Chemother.,1983

3. The pharmacokinetics and tissue penetration of intravenously administered CGP 31608;Wise;J Antimicrob Chemother.,1988

4. The significance of protein binding of antibiotics in antibacterial chemotherapy;Rolinson;J Antimicrob Chemother.,1980

5. Implementation of a once-daily aminoglycoside program in a large community-teaching hospital;Nicolau;Hosp Pharm.,1995

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3